Thromboprophylaxis with aspirin is as safe as low molecular weight heparin (LMWH) for the prevention of mortality in patients with orthopedic fractures. Researchers of the METRC trial are registering this The New England Journal of Medicine (2023;388:203-13). Although deep vein thrombosis (DVT) was more common in patients prescribed aspirin…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 32.95 for 12 weeks!
I want to meet
Do you already have a subscription? login
